Innovation Pharmaceuticals Inc (IPIX)

[HFM2]

Was in the $2K-$3K range, if I remember correctly, for Remd. At this point there is little left to argue here and much left to see. The drug is safe, works great, and hopefully will be widely available soon.
If it works as well as we think, it will be a direct challenge to many established industries, so we should not get caught thinking the powers that be only care about the health of humankind . . . as you well know, there is much money in treating disease. Can it be that B works too well and is thus perceived to be a wider threat than we can imagine? We will see soon enough . . . it will be a very good sign if the industry lets the peer review publications go forward - and critical to see where they get published (which journals). Grant funding will be another indication that the industry is "supportive." When FDA approval for P2 is granted and trials start, the eraser will have begun its earnest work on any lingering doubts.